| Literature DB >> 34522659 |
Pradhuman Verma1, Avinash Kumar2, Shantanu Dixit3, Kratika Mohan4, Nidhi Gupta5, Gourab Mandal6.
Abstract
INTRODUCTION: India is a high-risk region for oropharyngeal cancer (OC) due to high prevalence of tobacco, betel nut, and alcohol and accounts for 30% of all new cases of oral cancer annually.Entities:
Keywords: ABO blood groups; oral cancer; staging; tobacco
Year: 2021 PMID: 34522659 PMCID: PMC8407619 DOI: 10.4103/ams.ams_265_20
Source DB: PubMed Journal: Ann Maxillofac Surg ISSN: 2231-0746
Figure 1Various Oral Cancer sites noted in the study.
Age and gender distribution of patients
| Gender | Number of patients ( | Age (years), mean±SD |
|---|---|---|
| Female | 17 | 48.41±11.710 |
| Male | 56 | 52.11±14.183 |
| Total | 73 | 51.25±13.660 |
SD: Standard deviation
Age groups of the study population
| Age group (years) | Number of patients, |
|---|---|
| 20-30 | 6 (8.22) |
| 31-40 | 13 (17.81) |
| 41-50 | 21 (28.77) |
| 51-60 | 14 (19.18) |
| 61-70 | 14 (19.18) |
| >70 | 5 (6.85) |
Oral cancer diagnosis according to tumour-node-metastasis staging
| Diagnosis | Stage of OSCC | Total, | |||
|---|---|---|---|---|---|
|
| |||||
| I, | II, | III, | IV, | ||
| OSMF with SCC | 0 | 4 (5.5) | 1 (1.4) | 0 | 5 (6.9) |
| PIOC | 1 (1.4) | 1 (1.4) | 2 (2.7) | 0 | 4 (5.5) |
| PVL | 2 (2.7) | 0 | 0 | 0 | 2 (2.7) |
| SCC | 12 (16.4) | 26 (35.6) | 13 (17.8) | 10 (13.7) | 61 (83.6) |
| Verrucous carcinoma | 0 | 1 (1.4) | 0 | 0 | 1 (1.4) |
| Total | 15 (20.5) | 32 (43.8) | 16 (21.9) | 10 (13.7) | 73 (100.0) |
OSMF: Oral submucous fibrosis, SCC: Squamous cell carcinoma, PVL: Proliferative verrucous leukoplakia, OSCC: Oral SCC, PIOC: Primary intraosseous carcinoma
Border’s classification according to tumour-node-metastasis staging
| Border’s classification | Stage | Total, | |||
|---|---|---|---|---|---|
|
| |||||
| I, | II, | III, | IV, | ||
| Anaplastic | 0 | 0 | 2 (2.7) | 2 (2.7) | 4 (5.5) |
| Moderately differentiated | 5 (6.9) | 12 (16.4) | 2 (2.7) | 0 | 19 (26.1) |
| Poorly differentiated | 1 (1.4) | 4 (5.5) | 6 (8.2) | 5 (6.8) | 16 (21.9) |
| Well differentiated | 9 (12.3) | 16 (21.9) | 6 (8.2) | 3 (4.1) | 34 (46.6) |
| Total | 15 (20.5) | 32 (43.8) | 16 (21.9) | 10 (13.7) | 73 (100.0) |
Distribution of oral cancer sites according to deleterious habits
| Habits | Site | Total, | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
| ||||||||||
| Alveolar ridge, | Buccal mucosa, | Floor of mouth, | Gingivo-buccal sulcus, | Lip, | Palate, | Pharynx, | Retromolar trigone, | Tongue, | ||
| Alcoholic | 1 (1.4) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 (1.4) |
| Betalnut chewer | 1 (1.4) | 4 (5.5) | 0 | 0 | 0 | 1 (1.4) | 1 (1.4) | 0 | 1 (1.4) | 8 (11.0) |
| Combined | 14 (19.2) | 6 (8.2) | 2 (2.7) | 3 (4.1) | 0 | 0 | 1 (1.4) | 2 (2.7) | 1 (1.4) | 29 (39.7) |
| Denture irritation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 (1.4) | 1 (1.4) |
| Metastatic | 1 (1.4) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 (1.4) |
| No habit | 3 (4.1) | 0 | 0 | 0 | 0 | 1 (1.4) | 0 | 0 | 1 (1.4) | 5 (6.8) |
| Tobacco chewer | 11 (15.1) | 4 (5.5) | 0 | 1 (1.4) | 0 | 1 (1.4) | 0 | 0 | 3 (4.1) | 20 (27.4) |
| Tobacco smoker | 2 (2.7) | 0 | 0 | 0 | 2 (2.7) | 1 (1.4) | 0 | 3 (4.1) | 0 | 8 (11.0) |
| Total | 33 (45.2) | 14 (19.2) | 2 (2.7) | 4 (5.5) | 2 (2.7) | 4 (5.5) | 2 (2.7) | 5 (6.8) | 7 (9.6) | 73 (100.0) |
|
| 0.02* | 0.28 | 0.41 | 0.31 | 0.58 | 0.78 | 0.46 | 0.61 | 0.44 | |
*Statistically significant
Correlation of ABO blood groups and diagnosis of oral cancer
| Blood group | Diagnosis of OSCC | Total, | ||||
|---|---|---|---|---|---|---|
|
| ||||||
| OSMF with SCC, | PIOC, | PVL, | SCC, | Verrucous carcinoma, | ||
| A −ve | 0 | 0 | 0 | 1 (1.4) | 0 | 1 (1.4) |
| A +ve | 3 (4.1) | 1 (1.4) | 1 (1.4) | 33 (45.2) | 0 | 38 (52.1) |
| AB +ve | 0 | 0 | 0 | 3 (4.1) | 0 | 3 (4.1) |
| B −ve | 0 | 0 | 0 | 1 (1.4) | 0 | 1 (1.4) |
| B +ve | 0 | 2 (2.7) | 1 (1.4) | 11 (14.1) | 0 | 14 (19.2) |
| O −ve | 0 | 0 | 0 | 2 (2.7) | 0 | 2 (2.7) |
| O +ve | 2 (2.8) | 1 (1.4) | 0 | 10 (13.7) | 1 (1.4) | 14 (19.2) |
| Total | 5 (6.9) | 4 (5.5) | 2 (2.7) | 61 (83.6) | 1 (1.4) | 73 (100.0) |
|
| ||||||
|
|
|
| ||||
|
| ||||||
| A | 3.22 | |||||
| All other blood groups | 0.02* | |||||
*Statistically significant. OSMF: Oral submucous fibrosis, SCC: Squamous cell carcinoma, PVL: Proliferative verrucous leukoplakia, OSCC: Oral squamous cell carcinoma, PIOC: Primary intraosseous carcinoma, OR: Odds Ratio